|
|
Article: Cepheid makes second diagnostic acquisition.(Executive Briefing: News, Trends & Market Intelligence for Instrument Executives)
- Article from:
- Instrument Business Outlook
- Article date:
- February 15, 2007
CopyrightCOPYRIGHT 2007 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sunnyvale, CA 2/15/07 -- Cepheid, a provider of nucleic acid amplification equipment and reagents, has acquired Sangtec Molecular Diagnostics AB from ALTANA Pharma AG for $27 million in cash. Based in Broma, Sweden, Sangtec is a manufactuer of PCR-based molecular diagnostics products and had 2006 revenues of $8 million. Cepheid intends to integrate Sangtec's affigene kits for the immunocompromised market with in vitro ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cepheid Schedules Teleconference and Webcast for First ...
PR Newswire;
April 27, 2006 ;
700+ words
... ... available in the Investors section of Cepheid's web site for twelve months. A ... the conference ID is 11059387. About Cepheid Cepheid , based in Sunnyvale, Calif., is a molecular diagnostics company that develops, manufactures ...
|
|